Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP863600.RAG1g0L49pjCu6AoRvj_4nmB49lI-btlgBUUbg0-Dc6yk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP863600.RAG1g0L49pjCu6AoRvj_4nmB49lI-btlgBUUbg0-Dc6yk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP863600.RAG1g0L49pjCu6AoRvj_4nmB49lI-btlgBUUbg0-Dc6yk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP863600.RAG1g0L49pjCu6AoRvj_4nmB49lI-btlgBUUbg0-Dc6yk130_provenance.
- NP863600.RAG1g0L49pjCu6AoRvj_4nmB49lI-btlgBUUbg0-Dc6yk130_assertion description "[Prostate cancer was used as a paradigm because this tumor type is reliant at all stages of the disease on androgen receptor (AR) signaling, and cyclin D1 has been shown to negatively modulate AR-dependent expression of prostate-specific antigen (KLK3/PSA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863600.RAG1g0L49pjCu6AoRvj_4nmB49lI-btlgBUUbg0-Dc6yk130_provenance.
- NP863600.RAG1g0L49pjCu6AoRvj_4nmB49lI-btlgBUUbg0-Dc6yk130_assertion evidence source_evidence_literature NP863600.RAG1g0L49pjCu6AoRvj_4nmB49lI-btlgBUUbg0-Dc6yk130_provenance.
- NP863600.RAG1g0L49pjCu6AoRvj_4nmB49lI-btlgBUUbg0-Dc6yk130_assertion SIO_000772 21212260 NP863600.RAG1g0L49pjCu6AoRvj_4nmB49lI-btlgBUUbg0-Dc6yk130_provenance.
- NP863600.RAG1g0L49pjCu6AoRvj_4nmB49lI-btlgBUUbg0-Dc6yk130_assertion wasDerivedFrom befree-2016 NP863600.RAG1g0L49pjCu6AoRvj_4nmB49lI-btlgBUUbg0-Dc6yk130_provenance.
- NP863600.RAG1g0L49pjCu6AoRvj_4nmB49lI-btlgBUUbg0-Dc6yk130_assertion wasGeneratedBy ECO_0000203 NP863600.RAG1g0L49pjCu6AoRvj_4nmB49lI-btlgBUUbg0-Dc6yk130_provenance.
- befree-2016 importedOn "2016-02-19" NP863600.RAG1g0L49pjCu6AoRvj_4nmB49lI-btlgBUUbg0-Dc6yk130_provenance.